Skip to main content
SpringerLink
Log in

Pfizer-BioNTech COVID-19 vaccine safe with clozapine

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Lim S, et al. Haematological Changes and Adverse Events Associated with BNT162b2 mRNA COVID-19 Vaccine in Patients Receiving Clozapine - Findings from an Audit Acta Psychiatrica Scandinavica : 18 May 2022. Available from: URL: http://doi.org/10.1111/acps.13443

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Pfizer-BioNTech COVID-19 vaccine safe with clozapine. Reactions Weekly 1909, 12 (2022). https://doi.org/10.1007/s40278-022-16299-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-022-16299-8

Search

Navigation